Praziquantel enters a period of rapid development
In July 2019, the company's main product praziquantel officially entered the Russian market. It is expected that the annual demand is not less than 10 tons and the quality standard can meet USP4.0. Weijia obtained the praziquantel GMP certificate issued by the state in 2017. The factory has successively passed the audits of major international customers, and the GMP quality management system has been widely recognized.